Concepedia

Andrew Single

AS

Statistics

Publications

7

Citations

320

H-Index

7

Active since

2015

Affiliations

University of Otago(Current)

Lund University

Victoria University of Wellington

Skåne University Hospital

Andrew Single is an author at University of Otago specializing in cancer cell signaling, molecular oncology, and life sciences.

Publications per year

2015–2023

7

Publications

7

Small-molecule-mediated OGG1 inhibition attenuates pulmonary inflammation and lung fibrosis in a murine lung fibrosis model

Lloyd Tanner, Andrew Single, Ravi K. V. Bhongir et al. · Nature Communications · 2023 · 105 citations · Full text

Life Sciences, Molecular Biology, Pharmacology +12

A Comparison of Real-Time and Endpoint Cell Viability Assays for Improved Synthetic Lethal Drug Validation

Andrew Single, Henry Beetham, Bryony J. Telford et al. · SLAS DISCOVERY · 2015 · 83 citations · Full text

Medicine, Cell Biology, Pharmacology +17

Synthetic Lethal Screens Identify Vulnerabilities in GPCR Signaling and Cytoskeletal Organization in E-Cadherin–Deficient Cells

Bryony J. Telford, Augustine Chen, Henry Beetham et al. · Molecular Cancer Therapeutics · 2015 · 36 citations · Full text

Life Sciences, Molecular Biology, Oncology +16

E-cadherin-deficient cells have synthetic lethal vulnerabilities in plasma membrane organisation, dynamics and function

Tanis Godwin, S. Thomas Kelly, Tom P. Brew et al. · Gastric Cancer · 2018 · 33 citations · Full text

Life Sciences, Cell Biology, Oncology +17

Allosteric AKT Inhibitors Target Synthetic Lethal Vulnerabilities in E-Cadherin-Deficient Cells

Nicola Bougen‐Zhukov, Yasmin Nouri, Tanis Godwin et al. · Cancers · 2019 · 31 citations · Full text

Medicine, Cancer Biology, Oncology +16

1–5 of 7